These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1222721)

  • 1. Release of calcitonin by cultures of medullary carcinoma of the thyroid.
    Lichtenberger LM; Singer FR
    Endocr Res Commun; 1975; 2(8):527-36. PubMed ID: 1222721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the immunochemical forms of calcitonin released by a medullary thyroid carcinoma in tissue culture.
    Goltzman D; Tischler AS
    J Clin Invest; 1978 Feb; 61(2):449-58. PubMed ID: 621283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentagastrin, calcium and whisky stimulated serum calcitonin in medullary carcinoma of the thyroid.
    Emmertsen KK; Nielsen HE; Mosekilde L; Hansen HH
    Acta Radiol Oncol; 1980; 19(2):85-9. PubMed ID: 6254339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyrotrophin releasing hormone induced calcitonin secretion in patients with medullary carcinoma of the thyroid.
    Nakamura H; Someda H; Mori T; Imura H
    Clin Endocrinol (Oxf); 1987 Jul; 27(1):69-74. PubMed ID: 3115636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human calcitonin. Immunologic assay, cytologic localization and studies on medullary thyroid carcinoma.
    Tashjian AH; Wolfe HJ; Voelkel EF
    Am J Med; 1974 Jun; 56(6):840-9. PubMed ID: 4598527
    [No Abstract]   [Full Text] [Related]  

  • 6. Concomitant secretion of calcitonin, beta-endorphin and ACTH from medullary thyroid carcinoma in vivo and in vitro.
    Lamberts SW; Hackeng WH; Visser TJ
    Eur J Cancer Clin Oncol; 1982 Mar; 18(3):253-60. PubMed ID: 6284516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcitonin release from medullary thyroid carcinoma by thyrotropin-releasing hormone: comparison with calcium injection.
    Oishi S; Yamauchi J; Fujimoto Y; Hamasaki S; Umeda T; Sato T
    Acta Endocrinol (Copenh); 1992 Apr; 126(4):325-8. PubMed ID: 1595326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of voltage-dependent calcium channels in secretion of calcitonin from human medullary thyroid carcinoma cells.
    Raue F; Serve H; Grauer A; Rix E; Scherübl H; Schneider HG; Ziegler R
    Klin Wochenschr; 1989 Jun; 67(12):635-9. PubMed ID: 2475662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression and stimulation of calcitonin secretion in medullary thyroid carcinoma.
    Deftos LJ; Goodman AD; Engelman K; Potts JT
    Metabolism; 1971 Apr; 20(4):428-31. PubMed ID: 4994451
    [No Abstract]   [Full Text] [Related]  

  • 10. Calcitonin heterogeneity in lung cancer and medullary thyroid cancer.
    Becker KL; Snider RH; Silva OL; Moore CF
    Acta Endocrinol (Copenh); 1978 Sep; 89(1):89-99. PubMed ID: 211777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release of calcitonin gene-related peptide from a human medullary carcinoma of the thyroid in vitro.
    Ohashi M; Fujio N; Ibayashi H
    Experientia; 1986 Jul; 42(7):829-30. PubMed ID: 3488230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin inhibits the pentagastrin-induced release of serum calcitonin in medullary carcinoma of the thyroid.
    Gordin A; Lamberg BA; Pelkonen R; Almqvist S
    Clin Endocrinol (Oxf); 1978 Apr; 8(4):289-93. PubMed ID: 647984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimmunoassay of human calcitonin in serum and tissue from healthy individuals and patients with medullary carcinoma of the thyroid gland.
    Gautvik KM; Normann T; Teig V; Wille SO; Brennhovd IO; Christensen I
    Scand J Clin Lab Invest; 1976 Jul; 36(4):323-9. PubMed ID: 959750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medullary carcinoma and thyrocalcitonin.
    Tubiana M; Milhaud G; Coutris G; Lacour J; Parmentier C; Bok B
    Br Med J; 1968 Oct; 4(5623):87-9. PubMed ID: 5748583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretion of adrenocorticotropin, beta-endorphin and calcitonin by cultured medullary thyroid carcinoma cells. Effects of synthetic corticotropin-releasing factor and lysine vasopressin.
    Oosterom R; Verleun T; Bruining HA; Hackeng WH; Lamberts SW
    Acta Endocrinol (Copenh); 1986 Sep; 113(1):65-72. PubMed ID: 3020852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium stimulated calcitonin measurement: a procedural proposal.
    Verburg FA; Reiners C; Grelle I; Barth H; Fassnacht M; Luster M
    Exp Clin Endocrinol Diabetes; 2013 May; 121(5):318-20. PubMed ID: 23430575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor and plasma somatostatin-like immunoreactivity in transplantable rat medullary thyroid carcinoma.
    Birnbaum RS; Muszynski M; Roos BA
    Cancer Res; 1980 Nov; 40(11):4192-6. PubMed ID: 6110476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of region specific radioimmunoassays for characterization of circulating calcitonin in patients with medullary carcinoma of the thyroid gland.
    Myhre L; Gautvik KM
    Acta Endocrinol (Copenh); 1979 Jul; 91(3):449-61. PubMed ID: 474037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term excess of endogenous calcitonin in patients with medullary thyroid carcinoma does not affect bone mineral density.
    Wüster C; Raue F; Meyer C; Bergmann M; Ziegler R
    J Endocrinol; 1992 Jul; 134(1):141-7. PubMed ID: 1354241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioimmunoassay of calcitonin in plasma, normal thyroid, and medullary thyroid carcinoma of the rat.
    Roos BA; Deftos LJ; Roberts G; Wilson P; Bundy L
    J Lab Clin Med; 1976 Aug; 88(2):173-82. PubMed ID: 822106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.